Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
Here, we speak with Matthew Moorcroft, Vice President of Marketing & Intelligence at Cambrex.
The US opioid crisis has claimed the lives of hundreds of thousands. We examine pharma’s role.
Continuous processing, exporting generics and alleviating drug shortages… what’s new for pharma in business?
A new campaign highlights how far businesses have to go to close the gender pay gap – and pharma is no exception.
After a new approval and multi-million dollar deals, are ADCs finally moving to the forefront in the targeted therapy space?
The EMA has granted conditional marketing approval for Ervebo, the first vaccine to protect against Ebola.
Tony Hitchcock discusses his career and the evolution of the gene therapy market.
Brexit is a serious challenge for UK businesses trading with the EU.
Drug pricing concerns, facility expansions and regulatory changes... What’s new for pharma in business?
Single-use biotech process equipment is already making use of technology to automate processes and the level of complexity is increasing.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.